Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening

Future Oncology

Volumn 12, Issue 4, 2016, Pages 503-513

  Jenkins, Mark A ^a   Makalic, Enes ^a   Dowty, James G ^a   Schmidt, Daniel F ^a   Dite, Gillian S ^a   MacInnis, Robert J ^a,b   Ait Ouakrim, Driss ^a   Clendenning, Mark ^c   Flander, Louisa B ^a   Stanesby, Oliver K ^a   Hopper, John L ^a   Win, Aung K ^a   Buchanan, Daniel D ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cancer screening; colorectal cancer; risk prediction; single nucleotide polymorphisms

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; EUROPE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; PROCEDURES; RISK;

ALLELES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84957656764     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.15.303     Document Type: Article

References (44)

1. Vasen HF, Van Der Meulen-De Jong AE, De Vos Tot Nederveen Cappel WH, Oliveira J, Group EGW. Familial colorectal cancer risk: ESMO clinical recommendations. Ann. Oncol. 20(Suppl. 4), 51-53 (2009).
2. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 10(6), 353-358 (2009).
3. Welter D, Macarthur J, Morales J et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42, D1001-D1006 (2014).
4. Whiffin N, Dobbins SE, Hosking FJ et al. Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer. Hum. Mol. Genet. 22(24), 5075-5082 (2013).
5. Zhang B, Jia W-H, Matsuda K et al. Large-scale genetic study in east Asians identifies six new loci associated with colorectal cancer risk. Nat. Genet. 46(6), 533-542 (2014).
6. Michailidou K, Hall P, Gonzalez-Neira A et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45(4), 353-361, 361e1-361e2 (2013).
7. Al Olama AA, Kote-Jarai Z, Berndt SI et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat. Genet. 46(10), 1103-1109 (2014).
8. Dunlop MG, Tenesa A, Farrington SM et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 62(6), 871-881 (2013).
9. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3), 559-575 (2007).
10. PLINK. http://pngu.mgh.harvard.edu/purcell/plink/
11. Lubbe SJ, Di Bernardo MC, Broderick P, Chandler I, Houlston RS. Comprehensive evaluation of the impact of 14 genetic variants on colorectal cancer phenotype and risk. Am. J. Epidemiol. 175(1), 1-10 (2012).
12. Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and Mortality (ACIM) books: Colorectal cancer (also called bowel cancer) Canberra: AIHW (2015). www.aihw.gov.au/acim-books/
13. Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute, Bethesda, MD, USA. http://seer.cancer.gov/csr/1975-2012
14. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: Implications for design of association studies. Genet. Epidemiol. 25(3), 190-202 (2003).
15. Win AK, Dowty JG, Cleary SP et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146(5), 1208-1211, e1201-e1205 (2014).
16. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am. J. Gastroenterol. 96(10), 2992-3003 (2001).
17. Zhang B, Jia WH, Matsuo K et al. Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in east Asians. Int. J. Cancer 135(4), 948-955 (2014).
18. Dunlop MG, Dobbins SE, Farrington SM et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat. Genet. 44(7), 770-776 (2012).
19. Spain SL, Carvajal-Carmona LG, Howarth KM et al. Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13. Hum. Mol. Genet. 21(4), 934-946 (2012).
20. Haerian MS, Baum L, Haerian BS. Association of 8q24.21 loci with the risk of colorectal cancer: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 26(10), 1475-1484 (2011).
21. Tomlinson IPM, Carvajal-Carmona LG, Dobbins SE et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet. 7(6), e1002105 (2011).
22. Al-Tassan NA, Whiffin N, Hosking FJ et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci. Rep. 5, 10442 (2015).
23. Peters U, Hutter CM, Hsu L et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet. 131(2), 217-234 (2012).
24. Whiffin N, Hosking FJ, Farrington SM et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum. Mol. Genet. 23(17), 4729-4737 (2014).
25. Houlston RS, Cheadle J, Dobbins SE et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet. 42(11), 973-977 (2010).
26. Peters U, Jiao S, Schumacher FR et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology 144(4), 799-807 e724 (2013).
27. Schumacher F, Stenzel S, Jiao S et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat. Commun. 6, 7138 (2015).
28. Real LM, Ruiz A, Gayan J et al. A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysis. PLoS ONE 9(6), e101178 (2014).
29. Schmit SL, Schumacher FR, Edlund CK et al. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis 35(11), 2512-2519 (2014).
30. Jia WH, Zhang B, Matsuo K et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat. Genet. 45(2), 191-196 (2013).
31. Tomlinson IP, Webb E, Carvajal-Carmona L et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 40(5), 623-630 (2008).
32. Zanke BW, Greenwood CM, Rangrej J et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39(8), 989-994 (2007).
33. Tomlinson I, Webb E, Carvajal-Carmona L et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39(8), 984-988 (2007).
34. Kocarnik JD, Hutter CM, Slattery ML et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 19(12), 3131-3139 (2010).
35. Tenesa A, Campbell H, Theodoratou E et al. Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. Int. J. Obes. (Lond.) 33(2), 284-288 (2009).
36. Tomlinson IP, Carvajal-Carmona LG, Dobbins SE et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet. 7(6), e1002105 (2011).
37. Houlston RS, Webb E, Broderick P et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet. 40(12), 1426-1435 (2008).
38. Ryan BM, Wolff RK, Valeri N et al. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol. 38(5), 583-590 (2014).
39. Broderick P, Carvajal-Carmona L, Pittman AM et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet. 39(11), 1315-1317 (2007).
40. Hsu L, Jeon J, Brenner H et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology 148(7), 1330.e14-1339.e14 (2015).
41. Jiao S, Peters U, Berndt S et al. Estimating the heritability of colorectal cancer. Hum. Mol. Genet. 23(14), 3898-3905 (2014).
42. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst. Rev. (1), CD001216 (2007).
43. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348, g2467 (2014).
44. Ait Ouakrim D, Boussioutas A, Lockett T et al. Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev. Res. (Phila.) 5(2), 240-247 (2012).